Prairie Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Prairie Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,865	Closed	-$272K	–	153
2024 Q3	$272K	Buy	1,865 +100	+6%	+$14.5K	0.13%	121
2024 Q2	$242K	Buy	1,765 +100	+6%	+$13.3K	0.12%	129
2024 Q1	$228K	Buy	+1,665	New	+$227K	0.11%	150

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prairie Wealth Advisors's IBB Position: Q4 2024 in Review

Prairie Wealth Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 1,865 shares — an estimated $272K sold.

Prairie Wealth Advisors first reported a position in IBB in Q1 2024 and held it in 3 quarters. The position peaked at $272K in Q3 2024. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

Prairie Wealth Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
Prairie Wealth Advisors sold 1,865 iShares Biotechnology ETF shares in Q4 2024, an estimated $272K.
Prairie Wealth Advisors first reported a position in iShares Biotechnology ETF in Q1 2024 and held it in 3 quarters.
Prairie Wealth Advisors's iShares Biotechnology ETF position peaked at $272K in Q3 2024.
874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on Prairie Wealth Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.